Literature DB >> 2258069

Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases.

V M Abeler1, K E Kjørstad.   

Abstract

In a histological review of all 1985 cases of endometrial carcinoma in Norway diagnosed in the period 1970 through 1977, 22 patients (1.1%) with serous papillary carcinoma (ESPC) were identified. Mean age at diagnosis was 72 years, which was significantly higher than for patients with ordinary adenocarcinoma. All patients were followed at least 10 years. The crude 5- and 10-year survival rates were 27 and 14%. Only three patients survived longer than 10 years and all of these had had stage I tumors. In 19 available curettage specimens ESPC could be identified in 18. This could have implications regarding choice of therapy because this subtype of endometrial carcinoma is very aggressive. It is most often found in elderly women.

Entities:  

Mesh:

Year:  1990        PMID: 2258069     DOI: 10.1016/0090-8258(90)90250-o

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Practical issues in the diagnosis of serous carcinoma of the endometrium.

Authors:  Sonia Gatius; Xavier Matias-Guiu
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

2.  A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination.

Authors:  Kouichiro Kawano; Kimio Ushijima; Masato Yokomine; Akimasa Fukui; Morio Ijichi; Toshiharu Kamura
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

3.  The effect of cell type on surgico-pathologic risk factors in endometrial cancer.

Authors:  Ahmet Taner Turan; Betül Dündar; Burcu Gündoğdu; Abdullah Boztosun; Nejat Ozgül; Nurettin Boran; Gökhan Tulunay; Ahmet Ozfuttu; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-03-01

4.  The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women.

Authors:  Ian S Hagemann; Wei Deng; Richard J Zaino; Matthew A Powell; Camille Gunderson; Casey Cosgrove; Cara Mathews; Michael L Pearl; Steven Waggoner; Rahel Ghebre; Shashikant Lele; Saketh Guntupalli; Angeles Alvarez Secord; Olga Ioffe; Kay Park; Golnar Rasty; Meenakshi Singh; Robert Soslow; William Creasman; David G Mutch
Journal:  Gynecol Oncol       Date:  2021-01-08       Impact factor: 5.482

5.  DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.

Authors:  Manohar Pradhan; Ben Davidson; Vera Maria Abeler; Håvard Emil Danielsen; Claes Göran Tropé; Gunnar Balle Kristensen; Björn Åke Risberg
Journal:  Virchows Arch       Date:  2012-07-24       Impact factor: 4.064

6.  Management of women with surgically staged 1 uterine papillary serous cancer.

Authors:  Laurie Elit; Andre Laroche; Lauren Smith; John Mazurka; Francois Moens; Jan Hauspy; Waldo Jimenez
Journal:  ISRN Obstet Gynecol       Date:  2011-09-11

7.  Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.

Authors:  H Tsuda; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.